Provider News
OncoLink Cancer Resource Home

 

 
OncoLink Cancer Resource Home

Provider News and Information

OncoLink Cancer Resource Home
Types of Cancer Home
OncoLink Cancer Resource
Cancer Treatment Information Physician List
OncoLink Cancer Resource
Coping with Cancer MCC Staff
OncoLink Cancer Resource
Cancer Clinical Trials Matching Service Provider News
OncoLink Cancer Resource
Cancer Resources and News Women's News
OncoLink Cancer Resource
Ask the Cancer Experts Men's News
OncoLink Cancer Resource
OncoLink Cancer Library Treatment Protocols
OncoLink Cancer Resource
Cancer and Oncology Sponsors Cancer Control Protocols
OncoLink Cancer Resource
Giving to Oncolink's Cancer Resources Radiation Oncology
About Oncolink's Cancer Resources Upcoming Protocols
OncoLink
Giving to Oncolink's Cancer Resources Closed Protocols
Giving to Oncolink's Cancer Resources Related Links
   
 


 

 

MCC Administration

Benjamin Marchello, M.D.                 Principal Investigator bmarchello@hocnr.com

Grant Harrer, MD                               Co-Principal Investigator drharrer@benefis.net

James Burke, MD                                   NCCTG Group Lead jburke@billingsclinic.org

James Hueftle, MD                                 SWOG Group Lead jhueftle@prodigy.net

Thomas Warr, MD                                  NSABP Group Lead thomas.warr@gfclinic.com

David Myers, MD                                   Cancer Control Group Lead dmyers01@gmail.com


News and Information


Continuing Medical Education

Cooperative Group Meetings

NCCTG          April 7 -10, 2008 (registration 2/20)                                 SWOG            Apr 30 - May 4, 2008 (registration 2/26)                         RTOG             June 19 - 22, 2008                                              NSABP           June 13 - 15, 2008       Notes from Nov meeting

See Cooperative Group websites for registration                                    See Travel on this page for MCC policy and reimbursement information

Common Toxicity Criteria Tables

 

New Protocols Opened  (Updated 4/24/08)

Note:  JMA.17R now available for other patients not previously on JMA.17

Information on the New Breast Cancer Prevention Study - P-4 Appeal

S9921 Closed by DSM due to unexpected late side effects (Press Release)

Travel  

MCC Travel Policy                                      Travel Request Form                                  Travel Reimbursement Form

Investigational Agents                      PMB Distribution Policy

 

New Protocols               None new 4/24/08

                              Cancer Control 

NCCTG N06CA      Protocol  The Use of Topical Baclofen, Amitriptyline HCl, and Ketamine (BAK) in a PLO Gel vs. Placebo for the Treatment of Chemotherapy Induced Peripheral Neuropathy:  A Phase III Randomized Double-Blind Placebo Controlled Study

NCCTG N05C7    Protocol   Long  Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue:  A Phase III Randomized, Double-Blind Placebo Controlled Study

                                              

           

                                   Prevention

                                                  None

 
                                   Treatment Protocols

CTSU N063D ALTTO   Fast Facts    Protocol    A Randomized, Multi-center, Open-label, Phase III Study of Adjuvant Lapatinib, Trastuzumab, Their Sequence and Their Combination in Patients with HER2/ErbB2 Positive Primary Breast Cancer

CTSU C10501    Fast Facts    Protocol    A Phase III Intergroup CLL Study of Asymptomatic Patients with Untreated CLL Randomized to Early Intervention vs Observation with Later Treatment in Hi-Risk Genetic Subset with IgVh Unmutated Disease

NCCTG N0675   Protocol   A Phase II Study of Temozolomide and Everolimus (RAD-001) Therapy for Metastatic Melanoma

 

 

 

 

 

OncoLink Cancer Resource Home